These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 17890131)
1. In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans. Hougardy JM; Verscheure V; Locht C; Mascart F Microbes Infect; 2007 Sep; 9(11):1325-32. PubMed ID: 17890131 [TBL] [Abstract][Full Text] [Related]
2. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Ahn JS; Krishnadas DK; Agrawal B Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657 [TBL] [Abstract][Full Text] [Related]
3. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients. Li L; Lao SH; Wu CY Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131 [TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells in human autoimmune thyroid disease. Marazuela M; García-López MA; Figueroa-Vega N; de la Fuente H; Alvarado-Sánchez B; Monsiváis-Urenda A; Sánchez-Madrid F; González-Amaro R J Clin Endocrinol Metab; 2006 Sep; 91(9):3639-46. PubMed ID: 16804051 [TBL] [Abstract][Full Text] [Related]
5. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC. Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059 [TBL] [Abstract][Full Text] [Related]
7. Regulatory T-cell subsets in response to specific Mycobacterium tuberculosis antigens in vitro distinguish among individuals with different QTF and TST reactivity. Serrano CJ; Castañeda-Delgado JE; Trujillo-Ochoa JL; González-Amaro R; García-Hernández MH; Enciso-Moreno JA Clin Immunol; 2015 Apr; 157(2):145-55. PubMed ID: 25728490 [TBL] [Abstract][Full Text] [Related]
8. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115 [TBL] [Abstract][Full Text] [Related]
9. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171 [TBL] [Abstract][Full Text] [Related]
10. CD4 Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848 [TBL] [Abstract][Full Text] [Related]
11. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. Cavassani KA; Campanelli AP; Moreira AP; Vancim JO; Vitali LH; Mamede RC; Martinez R; Silva JS J Immunol; 2006 Nov; 177(9):5811-8. PubMed ID: 17056505 [TBL] [Abstract][Full Text] [Related]
12. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270 [TBL] [Abstract][Full Text] [Related]
13. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Clark RA; Kupper TS Blood; 2007 Jan; 109(1):194-202. PubMed ID: 16968902 [TBL] [Abstract][Full Text] [Related]
14. [Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus]. Alunno A; Nocentini G; Bistoni O; Bianchini R; Bartoloni Bocci E; Riccardi C; Gerli R Reumatismo; 2010; 62(3):195-201. PubMed ID: 21052566 [TBL] [Abstract][Full Text] [Related]
15. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Chen X; Subleski JJ; Hamano R; Howard OM; Wiltrout RH; Oppenheim JJ Eur J Immunol; 2010 Apr; 40(4):1099-106. PubMed ID: 20127680 [TBL] [Abstract][Full Text] [Related]
16. The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells. Kreijveld E; Koenen HJ; Hilbrands LB; van Hooff HJ; Joosten I Blood; 2007 Jan; 109(1):244-52. PubMed ID: 16902146 [TBL] [Abstract][Full Text] [Related]
17. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression. Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772 [TBL] [Abstract][Full Text] [Related]
19. A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Ribeiro-Rodrigues R; Resende Co T; Rojas R; Toossi Z; Dietze R; Boom WH; Maciel E; Hirsch CS Clin Exp Immunol; 2006 Apr; 144(1):25-34. PubMed ID: 16542361 [TBL] [Abstract][Full Text] [Related]
20. Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells. Montcuquet N; Mercier-Letondal P; Perruche S; Duperrier A; Couturier M; Bouchekioua A; Bonyhadi M; Ferrand C; Tiberghien P; Robinet E Immunology; 2008 Nov; 125(3):320-30. PubMed ID: 18445006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]